Dyne Therapeutics, Inc. (DYN) NASDAQ

Currency In USD

Dyne Therapeutics, Inc.

Address

1560 Trapelo Road

Waltham, MA 02451

United States of America (the)

Phone

781 786 8230

Website

https://www.dyne-tx.com

Sector

Healthcare

Industry

Biotechnology

Employees

192

First IPO Date

September 17, 2020

Key Executives

Name	Title	Pay	Year Born
John G. Cox	Chief Executive Officer, President & Director	1.14M	1963
Vikram Ranade	Chief Business Officer	662,344	N/A
Erick J. Lucera	Chief Financial Officer, Principal Financial Officer & Principal Accounting Officer and Treasurer	726,892	1968
Oxana Beskrovnaya	Chief Innovation Officer	740,475	1961
Douglas Kerr	Chief Medical Officer	748,065	1967
Johanna Friedl-Naderer	Chief Commercial Officer	842,754	1968
James Bilotta	Chief Digital & Information Officer	0	N/A
Debra Feldman	Chief Regulatory Affairs Officer	0	1971
Lucia Celona	Chief Human Resource Officer	0	1966
Monica Fay	Chief Medical Affairs Officer	0	N/A
Rajesh Manchanda	Chief Technical Officer	0	1967
Jose Juves	Chief Corporate & Patient Affairs Officer	0	N/A
Daniel Wilson	Senior Vice President & Head of Legal	0	1972
Axel Wiest	Senior VP and Head of Portfolio Strategy & Operations	0	N/A

Description

Dyne Therapeutics, Inc. is a U.S.-based biotechnology firm focused on developing advanced treatments for genetically driven muscle disorders. Utilizing its proprietary FORCE platform, which is engineered to deliver disease-modifying therapeutics, the company is actively engaged in various programs. These initiatives target conditions such as myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral dystrophy, in addition to other rare skeletal, cardiac, and metabolic muscle diseases. The company was founded in 2017 and maintains its corporate headquarters in Waltham, Massachusetts.